Clinical Trials
155
Active:7
Completed:114
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:7
Phase 2:10
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (117 trials with phase data)• Click on a phase to view related trials
Not Applicable
87 (74.4%)Phase 4
11 (9.4%)Phase 2
10 (8.5%)Phase 1
7 (6.0%)Early Phase 1
1 (0.9%)Phase 3
1 (0.9%)TMS in Anxiety-Parkinson's Disease
Not Applicable
Not yet recruiting
- Conditions
- Parkinsons Disease (PD)Anxiety
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06999330
- Locations
- 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Pilot TMS in Mild TBI
Not Applicable
- Conditions
- Persistent Post Concussive HeadacheMild Traumatic Brain Injury
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 20
- Registration Number
- NCT06999304
- Locations
- 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
ACL Reconstruction Rehabilitation With Exercise and Psychological Support
Not Applicable
Recruiting
- Conditions
- Anterior Cruciate Ligament Reconstruction Rehabilitation
- First Posted Date
- 2025-05-27
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 60
- Registration Number
- NCT06991192
- Locations
- 🇺🇸
TRIA, Bloomington, Minnesota, United States
Utilizing 3D Imaging for Burn Wound Assessment
Recruiting
- Conditions
- Burn2nd Degree Burn of the Skin3rd Degree Burn of the Skin1st Degree Burn of the Skin
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 75
- Registration Number
- NCT06938061
- Locations
- 🇺🇸
Regions Hospital Burn Clinic, Saint Paul, Minnesota, United States
Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes
Not Applicable
Not yet recruiting
- Conditions
- Hereditary Breast/Ovarian Cancer (brca1, brca2)Lynch SyndromeGenetic VariationHBOC SyndromeHereditary Cancer Syndromes
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 2488
- Registration Number
- NCT06914726
- Locations
- 🇺🇸
HealthPartners Medical Group, Minneapolis, Minnesota, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 31
- Next
News
Once-Weekly Insulin Icodec Combined with CGM Shows Promising Results for Type 2 Diabetes Management
Adults with type 2 diabetes achieved significant HbA1c reduction from 8.18% to 7% over 26 weeks using once-weekly insulin icodec combined with continuous glucose monitoring in the ONWARDS 9 trial.